Details of the Drug | DrugMAP

General Information of Drug (ID: DMUGVNA)

Drug Name

VBY-825

Indication

Disease Entry	ICD 11	Status	REF
Coronavirus Disease 2019 (COVID-19)	1D6Y	Investigative	[1]
------------------------------------------------------------------------------------

Drug Type

Small molecular drug

Structure

3D MOL is unavailable

2D MOL

Chemical Identifiers

Formula: C23H29F4N3O5S
Canonical SMILES: CCC(C(=O)C(=O)NC1CC1)NC(=O)C(CS(=O)(=O)CC2CC2)NC(C3=CC=C(C=C3)F)C(F)(F)F
InChI: 1S/C23H29F4N3O5S/c1-2-17(19(31)22(33)28-16-9-10-16)30-21(32)18(12-36(34,35)11-13-3-4-13)29-20(23(25,26)27)14-5-7-15(24)8-6-14/h5-8,13,16-18,20,29H,2-4,9-12H2,1H3,(H,28,33)(H,30,32)/t17-,18-,20-/m0/s1
InChIKey: PPUXXDKQNAHHON-BJLQDIEVSA-N

Cross-matching ID

PubChem CID: 70945511
CAS Number: 1310340-58-9
TTD ID: D0HH3W

References

1	A Large-scale Drug Repositioning Survey for SARS-CoV-2 Antivirals. April 17, 2020.